Dr. Jonathan Trent is a board-certified oncologist, professor of medicine at the University of Miami Miller School of Medicine and the co-director of the University of Miami Health System Musculoskeletal Center, Sarcoma Medical Research Program. His team focuses on developing breakthroughs in gene discovery that enable improved precision medicine for cancer patients. He has produced more than 100 peer-reviewed articles, served on many editorial boards and presented at numerous conferences.
Dr. Trent earned his undergraduate degree in chemistry at Southeastern Oklahoma State University and his M.D. and Ph.D. in cancer biology from the University of Texas Health Science Center. His internship and residency in internal medicine were completed at the University of Texas Health Science Center, and he was chief fellow while completing his fellowship in medical oncology at the University of Texas MD Anderson Cancer Center. He earned his board certification from the American Board of Internal Medicine in 1999. Prior to his current appointment, Dr. Trent served as an assistant professor at the department of sarcoma medical oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas.
Throughout his career, Dr. Trent has incorporated research and teaching while treating patients. His research has been used to devise treatments for patients based upon their individual needs. These treatments include medicines Dr. Trent developed that target the specific genes a cancer uses to grow in a patient. Patients are now receiving care designed to attack the specific cancer in their own bodies.
Dr. Trent serves on the Sylvester Comprehensive Cancer Center's executive committee as the associate director for clinical research.